Physician profile
Shannon Ross
NPI 1588621445
$1,888.33
in general payments reported to CMS, 2019-2025
19 companies · $812 in 2025
The $812 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $496 · 2024: $581 · 2025: $812.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,689 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,689.34 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $617.36 | 2023-2025 | |
| Janssen Biotech, INC. | $243.13 | 2023-2025 | Tremfya |
| Lilly USA, LLC | $187.17 | 2023-2025 | Taltz, Olumiant, Ebglyss |
| Amgen INC. | $151.30 | 2023-2025 | Otezla, Otezla |
| Sun Pharmaceutical Industries INC. | $133.47 | 2023-2025 | Winlevi, Ilumya |
| Regeneron Healthcare Solutions, INC. | $88.55 | 2023-2024 | Dupixent |
| Galderma Laboratories, L.P. | $76.57 | 2023-2025 | Nemluvio, Aklief |
| Novartis Pharmaceuticals Corporation | $66.97 | 2023-2024 | |
| Pfizer INC. | $60.88 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $41.03 | 2024-2025 | Cabtreo |
| Ucb, INC. | $39.45 | 2023-2024 | Cimzia, Bimzelx |
| Organon LLC | $38.66 | 2025 | Vtama |
| Genzyme Corporation | $24.78 | 2024 | |
| Arcutis Biotherapeutics, INC. | $21.75 | 2025 | Zoryve |
| Botanix Sb INC | $21.49 | 2025 | Sofdra |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $20.55 | 2025 | Seysara |
| Leo Pharma INC. | $19.56 | 2024 | Adbry |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.36 | 2023 | Spevigo |
| Dermavant Sciences, INC. | $16.30 | 2023 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.